Huapont Life Sciences Co., Ltd. (002004.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap9.43B
Enterprise Value11.79B
P/E Ratio12.3
PEG Ratio0.01
Price/Sales Ratio0.72
Price/Book Ratio0.79
Enterprise/Revenue1.13
Enterprise/EBITDA5.96

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.06
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.07

Income Statement

Revenue11.51B
Revenue/Share5.83
Gross Profit4.25B
EBITDA2.43B
Net Income713.19M
Diluted EPS0.36

Balance Sheet

Total Cash4.9B
Total Cash/Share2.48
Total Debt8.75B
Total Debt/Equity0.84
Current Ratio1.4
Book Value Per Share8.79

Price History

52-Week Change1.95
52-Week High6.08
52-Week Low3.88
Moving Average 50 Days4.77
Moving Average 200 Days4.99

Statistics

Average Volume26.96M
Shares Outstanding1.98B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.45
Trailing Annual Dividend Yield10.77
Payout Ratio0.28
Last Split Factor5:2
Last Split DateMay 27, 2015
AD